手法を比較

	機械学習支援系統解析	ゲノムワイド関連解析 (GWAS)
分野	バイオインフォマティクス	バイオインフォマティクス
系統	Process / pipeline	Process / pipeline
提唱年	2000s–2020s (active development phase 2018–present)	2005–2007
提唱者	Multiple contributors; early applications by Kolaczkowski & Thornton (2004) for model selection; deep learning formulations by Suvorov et al. (2020) and Zou et al. (2020)	Klein et al. (age-related macular degeneration GWAS, 2005); landmark scale: Wellcome Trust Case Control Consortium (2007)
種類	Computational inference pipeline	Observational genomic association study
原典	Nesterenko, L., et al. (2024). Machine learning methods in phylogenetics: A review of applications and perspectives. Briefings in Bioinformatics, 25(1), bbad441.	Wellcome Trust Case Control Consortium. (2007). Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature, 447(7145), 661–678.
別名	ML-based phylogenetics, deep learning phylogenetics, neural network tree inference, ML phylogenomics	GWAS, genome-wide association analysis, whole-genome association study, WGAS
関連	1	6
概要	Machine learning-assisted phylogenetic analysis integrates supervised, unsupervised, or deep learning models into the evolutionary tree inference workflow to improve speed, accuracy, or scalability beyond what classical maximum-likelihood and Bayesian methods achieve alone. Applications range from substitution model selection and tree topology prediction to placement of novel sequences onto existing reference trees and detection of recombination or horizontal gene transfer events.	A genome-wide association study (GWAS) systematically tests hundreds of thousands to millions of single-nucleotide polymorphisms (SNPs) across the human genome for statistical association with a trait or disease. By comparing allele frequencies between cases and controls — or by regressing SNP genotypes on a quantitative phenotype — GWAS identifies genomic loci that harbor common genetic variants contributing to complex traits. Since its large-scale debut in 2007, GWAS has catalogued thousands of robust disease–variant associations across virtually every common human condition.